ACTIVE

APOTHEEK HET LAAR

Export PDF

Financial year 2025 · closed on 30/09/2025

Net result

69,3 k €

+18.1% YoY

Gross margin

175,9 k €

-14.8% YoY

Equity

160,6 k €

-20.2% YoY

Workforce

0,9 ETP

-47.1% YoY

What does APOTHEEK HET LAAR do?

APOTHEEK HET LAAR is a Private limited company incorporated in 1977. Its registered office is in Beveren-Kruibeke-Zwijndrecht. It employs on average 0,9 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0417.733.765

Incorporation

27/11/1977

Legal form

Private limited company

Registered office

Burchtsestraat 13A
2070 Beveren-Kruibeke-Zwijndrecht · FlandreSee on map

Contributed capital

18 592,01 €

Latest accounts

30/09/2025

Average workforce

0,9 ETP

Joint committees (1)

Signals

ProfitableLow riskPositive cashflowPositive EBITDAHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 20 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007		2006
Income statement
Gross margin	175,9 k €	-14.8%	206,5 k €	-19.6%	256,9 k €	-1.7%	261,4 k €	+17.8%	221,9 k €	-12.7%	254,1 k €	+9.2%	232,7 k €	+4.1%	223,6 k €	+11.8%	200 k €	+74.1%	114,9 k €	+29.8%	88,5 k €	+51.3%	58,5 k €	-19.6%	72,7 k €	+38.3%	52,6 k €	+32.2%	39,8 k €	-15.6%	47,1 k €	-6.9%	50,6 k €	+33.6%	37,9 k €	+14.9%	32,9 k €	+76.3%	18,7 k €
EBITDA	128,1 k €	+9.8%	116,6 k €	-25.1%	155,8 k €	-6.0%	165,6 k €	+27.3%	130,1 k €	-30.8%	188,2 k €	+1.6%	185,2 k €	-5.2%	195,3 k €	+9.1%	179 k €	+56.6%	114,3 k €	+47.4%	77,5 k €	+93.2%	40,1 k €	-19.5%	49,9 k €	+62.4%	30,7 k €	+71.0%	18 k €	-36.2%	28,2 k €	-9.9%	31,3 k €	+62.9%	19,2 k €	+20.5%	15,9 k €	+679%	2 k €
Operating result	100,6 k €	+13.9%	88,4 k €	-31.1%	128,2 k €	-7.6%	138,8 k €	+33.3%	104,1 k €	-35.7%	162 k €	+2.8%	157,6 k €	-6.6%	168,8 k €	+12.2%	150,4 k €	+46.1%	102,9 k €	+97.7%	52,1 k €	+29.7%	40,1 k €	-19.5%	49,9 k €	+62.4%	30,7 k €	+81.1%	17 k €	-37.6%	27,2 k €	-4.5%	28,4 k €	+82.3%	15,6 k €	+26.5%	12,3 k €	+756%	-1,9 k €
Net result	69,3 k €	+18.1%	58,7 k €	-41.8%	100,9 k €	-12.5%	115,3 k €	+18.0%	97,7 k €	-26.9%	133,6 k €	-10.6%	149,4 k €	-6.5%	159,8 k €	+12.3%	142,3 k €	+54.6%	92 k €	+94.0%	47,4 k €	+78.2%	26,6 k €	-21.1%	33,8 k €	+33.4%	25,3 k €	+85.2%	13,7 k €	-34.2%	20,8 k €	-0.2%	20,8 k €	+39.7%	14,9 k €	+22.5%	12,2 k €	+548%	-2,7 k €
Balance sheet
Equity	160,6 k €	-20.2%	201,3 k €	+41.2%	142,5 k €	+66.3%	85,7 k €	+129%	37,5 k €	-2.1%	38,3 k €	-74.2%	148,6 k €	-2.2%	151,9 k €	+1.2%	150,1 k €	+1.5%	147,9 k €	+13.9%	129,8 k €	-55.1%	289,4 k €	+10.1%	262,8 k €	+14.7%	229 k €	+12.4%	203,7 k €	+7.2%	190 k €	+12.3%	169,3 k €	+14.0%	148,5 k €	+11.2%	133,6 k €	+10.0%	121,4 k €
Total assets	783,7 k €	+12.8%	694,6 k €	-0.8%	700,3 k €	-4.0%	729,8 k €	-14.7%	855,4 k €	+6.8%	800,9 k €	-5.9%	851,4 k €	+13.1%	752,7 k €	+14.7%	656,5 k €	+69.1%	388,3 k €	-25.8%	523,5 k €	+66.3%	314,7 k €	+9.2%	288,3 k €	+15.8%	248,8 k €	+11.9%	222,4 k €	+5.2%	211,5 k €	+6.5%	198,6 k €	+19.9%	165,6 k €	+4.9%	157,8 k €	+17.6%	134,2 k €
Cash	144,1 k €	-21.8%	184,2 k €	-2.2%	188,4 k €	-15.0%	221,8 k €	-40.4%	372,4 k €	+4.8%	355,3 k €	-13.7%	411,8 k €	+43.5%	287 k €	+42.3%	201,7 k €	+65.1%	122,2 k €	-56.8%	282,7 k €	+9.8%	257,5 k €	+12.2%	229,6 k €	+19.8%	191,6 k €	+349%	42,7 k €	+61.3%	26,5 k €	-12.0%	30,1 k €	-71.8%	106,8 k €	+18.2%	90,4 k €	+1563%	5,4 k €
Debts	619,5 k €	+27.3%	486,8 k €	-12.1%	553,9 k €	-13.7%	641,7 k €	-21.4%	816 k €	+7.3%	760,3 k €	+8.5%	701,1 k €	+16.9%	599,6 k €	+18.6%	505,4 k €	+112%	239 k €	-39.3%	393,4 k €	+1478%	24,9 k €	+0.5%	24,8 k €	+25.0%	19,8 k €	+19.4%	16,6 k €	-22.6%	21,5 k €	-18.5%	26,3 k €	+53.3%	17,2 k €	-29.2%	24,3 k €	+89.6%	12,8 k €
Other
Workforce	0,9 ETP	-47.1%	1,7 ETP	-41.4%	2,9 ETP	+45.0%	2,0 ETP	0.0%	2,0 ETP	+17.6%	1,7 ETP	+30.8%	1,3 ETP	+62.5%	0,8 ETP	+60.0%	0,5 ETP		–		0,4 ETP	-33.3%	0,6 ETP	0.0%	0,6 ETP	0.0%	0,6 ETP	0.0%	0,6 ETP	0.0%	0,6 ETP	0.0%	0,6 ETP	0.0%	0,6 ETP	0.0%	0,6 ETP	0.0%	0,6 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 500 k€ and 1 M€

See the valuation

Governance

Board of directors

Seen on filing of 30/09/2025 · 1 active · 8 ended

Active mandates

D & D Invest

Director · since 30 septembre 2014 · 0818.806.197

Represented by Dieleman Alice

Active

Ended mandates

D & D Invest

Manager · since 30 septembre 2014 · 0818.806.197

Represented by Alice Dieleman

Ended

D & D Invest

Director · since 30 septembre 2014 · 0818.806.197

Represented by Dieleman ALICE

Ended

D & D Invest

Mandate · since 30 septembre 2014 · 0818.806.197

Represented by Alice Dieleman

Ended

D & D Invest

Manager · since 30 septembre 2014 · 0818.806.197

Represented by Alice Dieleman

Ended

At this address

Other companies at this address

Company	CBE no.
Vereniging van Mede-eigenaars gebouw "Residentie Het Laar" te 2070 Zwijndrecht, Burchtsestraat 13A / Jan Baptist Tassynsstraat 190● Active	0506.714.736

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/10/2024	01/10/2023	01/10/2022	01/10/2021	01/10/2020	01/10/2019
Closing of the financial year	30/09/2025	30/09/2024	30/09/2023	30/09/2022	30/09/2021	30/09/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	03/04/2026	01/04/2025	03/04/2024	24/04/2023	29/03/2022	29/03/2021
General meeting	21/03/2026	15/03/2025	18/03/2024	20/03/2023	19/03/2022	20/03/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

20 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	30/09/2025	21/03/2026	03/04/2026	Dutch	PDF
Abridged model	30/09/2024	15/03/2025	01/04/2025	Dutch	PDF
Abridged model	30/09/2023	18/03/2024	03/04/2024	Dutch	PDF
Abridged model	30/09/2022	20/03/2023	24/04/2023	Dutch	PDF
Abridged model	30/09/2021	19/03/2022	29/03/2022	Dutch	PDF
Abridged model	30/09/2020	20/03/2021	29/03/2021	Dutch	PDF
Abridged model	30/09/2019	21/03/2020	27/03/2020	Dutch	PDF
Abridged model	30/09/2018	16/03/2019	28/03/2019	Dutch	PDF
Abridged model	30/09/2017	17/03/2018	30/03/2018	Dutch	PDF
Abridged model	30/09/2016	18/03/2017	29/03/2017	Dutch	PDF
Abridged model	30/09/2015	19/03/2016	27/03/2016	Dutch	PDF
Abridged model	30/09/2014	21/03/2015	02/04/2015	Dutch	PDF
Abridged model	31/12/2013	07/06/2014	23/06/2014	Dutch	PDF
Abridged model	31/12/2012	01/06/2013	11/06/2013	Dutch	PDF
Abridged model	31/12/2011	04/06/2012	27/06/2012	Dutch	PDF
Abridged model	31/12/2010	04/06/2011	28/06/2011	Dutch	PDF
Abridged model	31/12/2009	05/06/2010	30/06/2010	Dutch	PDF
Abridged model	31/12/2008	06/06/2009	03/07/2009	Dutch	PDF
Abridged model	31/12/2007	07/06/2008	04/07/2008	Dutch	PDF
Abridged model	31/12/2006	02/06/2007	13/06/2007	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 500 k€ and 1 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 30/09/2025 · 1 active · 8 ended

Active mandates

D & D Invest

Director · since 30 septembre 2014 · 0818.806.197

Represented by Dieleman Alice

Active

Ended mandates

D & D Invest

Manager · since 30 septembre 2014 · 0818.806.197

Represented by Alice Dieleman

Ended

D & D Invest

Director · since 30 septembre 2014 · 0818.806.197

Represented by Dieleman ALICE

Ended

D & D Invest

Mandate · since 30 septembre 2014 · 0818.806.197

Represented by Alice Dieleman

Ended

D & D Invest

Manager · since 30 septembre 2014 · 0818.806.197

Represented by Alice Dieleman

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates24/10/2023
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - ONTSLAGEN - BENOEMINGEN
PDF
Mandates20/10/2014
BENAMING - KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN - BOEKJAAR
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 202569,3 k €↑
2024
Annual accounts 202458,7 k €↓
2023
Annual accounts 2023100,9 k €↓
2022
Annual accounts 2022115,3 k €↑
2021
Annual accounts 202197,7 k €↓
2020
Annual accounts 2020133,6 k €↓
2019
Annual accounts 2019149,4 k €↓
2018
Annual accounts 2018159,8 k €↑
2017
Annual accounts 2017142,3 k €↑
2016
Annual accounts 201692 k €↑
2015
Annual accounts 201547,4 k €↑
2014
Annual accounts 201426,6 k €↓
2013
Annual accounts 201333,8 k €↑
2012
Annual accounts 201225,3 k €↑
2011
Annual accounts 201113,7 k €↓
2010
Annual accounts 201020,8 k €↓
2009
Annual accounts 200920,8 k €↑
2008
Annual accounts 200814,9 k €↑
2007
Annual accounts 200712,2 k €↑
2006
Annual accounts 2006-2,7 k €
27/11/1977
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

APOTHEEK HET LAAR

Overview

What does APOTHEEK HET LAAR do?

Trend over 20 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline